Table 1.

Demographic and clinical parameters of TB patients.

Low RespondersHigh RespondersPTest
Number5420
Age (year)33.94 ± 1.92230.59 ± 2.5730.1584Mann-Whitney test
SexFemale48.98%65.22%0.2169Fisher exact test
Male51.02%34.78%
EthnicityCaucasian78.72%95.00%0.1529Fisher exact test
American Indian21.28%5.00%
Albumin (g/dl)2.806 ± 0.10353.45 ± 0.160.0005Unpaired t test
Leucocytes (cells/ml)10109 ± 497.39920 ± 664.70.4157Mann-Whitney test
Lymphocytes (cells/ml)1368 ± 100.21845 ± 269.70.022Mann-Whitney test
Neutrophils (cells/ml)7566 ± 460.26866 ± 498.30.1804Mann-Whitney test
Monocytes (cells/mL)771.9 ± 66.76839.0 ± 83.60.2769Mann-Whitney test
Neutrophil/Lymphocyte Ratio7.609 ± 0.96144.693 ± 0.500.0255Mann-Whitney test
Time of Disease Evolution (months)4.227 ± 0.45362.375 ± 0.47240.0118Mann-Whitney test
RadiologyMild/Moderate24.00%42.11%0.0109Fisher exact test
Severe76.00%57.89%
AFB0/“+”18.75%55.00%0.0071Fisher exact test
“++”/“+++”81.25%45.00%
IFN-γ index29.2 ± 9.2229.3 ± 70.4<0.0001Mann-Whitney test
Proliferation index7.0 ± 0.9926.6 ± 2.9<0.0001Mann-Whitney test
Increase in the % of SLAMF1+ T cells2.2 ± 0.5010.9 ± 1.4<0.0001Mann-Whitney test
Low RespondersHigh RespondersPTest
Number5420
Age (year)33.94 ± 1.92230.59 ± 2.5730.1584Mann-Whitney test
SexFemale48.98%65.22%0.2169Fisher exact test
Male51.02%34.78%
EthnicityCaucasian78.72%95.00%0.1529Fisher exact test
American Indian21.28%5.00%
Albumin (g/dl)2.806 ± 0.10353.45 ± 0.160.0005Unpaired t test
Leucocytes (cells/ml)10109 ± 497.39920 ± 664.70.4157Mann-Whitney test
Lymphocytes (cells/ml)1368 ± 100.21845 ± 269.70.022Mann-Whitney test
Neutrophils (cells/ml)7566 ± 460.26866 ± 498.30.1804Mann-Whitney test
Monocytes (cells/mL)771.9 ± 66.76839.0 ± 83.60.2769Mann-Whitney test
Neutrophil/Lymphocyte Ratio7.609 ± 0.96144.693 ± 0.500.0255Mann-Whitney test
Time of Disease Evolution (months)4.227 ± 0.45362.375 ± 0.47240.0118Mann-Whitney test
RadiologyMild/Moderate24.00%42.11%0.0109Fisher exact test
Severe76.00%57.89%
AFB0/“+”18.75%55.00%0.0071Fisher exact test
“++”/“+++”81.25%45.00%
IFN-γ index29.2 ± 9.2229.3 ± 70.4<0.0001Mann-Whitney test
Proliferation index7.0 ± 0.9926.6 ± 2.9<0.0001Mann-Whitney test
Increase in the % of SLAMF1+ T cells2.2 ± 0.5010.9 ± 1.4<0.0001Mann-Whitney test

Immunological classification of TB patients as High and Low Responders (HR and LR) was performed according to the IFN-γ index; proliferation index and increase in the percentage of SLAMF1+ T cells in response to Mtb-Ag stimulation. Clinical symptoms analyzed in TB patients previous to hospital admission to establish the time (months) of disease evolution were: weight loss, night sweats, symptoms of malaise or weakness, persistent fever, presence of cough, history of shortness of breath, and hemoptysis. Radiological lesions: “mild” corresponds to patients with a single lobe involved and without visible cavities; “moderate” relates to patients presenting unilateral involvement of two or more lobes with cavities, if present, reaching a total diameter no greater than 4 cm; “severe” corresponds to bilateral disease with massive affectation and multiple cavities. Acid-Fast Bacilli (AFB) in sputum smear represent: AFB-, 0 bacilli count; AFB +, 1–9 bacilli/100 fields; AFB + +, 1–9 bacilli/10 fields; AFB + + + , 1–9 bacilli/field. Continuous data are expressed as mean ± SEM, and categorical data are expressed as number (percentages).

Table 1.

Demographic and clinical parameters of TB patients.

Low RespondersHigh RespondersPTest
Number5420
Age (year)33.94 ± 1.92230.59 ± 2.5730.1584Mann-Whitney test
SexFemale48.98%65.22%0.2169Fisher exact test
Male51.02%34.78%
EthnicityCaucasian78.72%95.00%0.1529Fisher exact test
American Indian21.28%5.00%
Albumin (g/dl)2.806 ± 0.10353.45 ± 0.160.0005Unpaired t test
Leucocytes (cells/ml)10109 ± 497.39920 ± 664.70.4157Mann-Whitney test
Lymphocytes (cells/ml)1368 ± 100.21845 ± 269.70.022Mann-Whitney test
Neutrophils (cells/ml)7566 ± 460.26866 ± 498.30.1804Mann-Whitney test
Monocytes (cells/mL)771.9 ± 66.76839.0 ± 83.60.2769Mann-Whitney test
Neutrophil/Lymphocyte Ratio7.609 ± 0.96144.693 ± 0.500.0255Mann-Whitney test
Time of Disease Evolution (months)4.227 ± 0.45362.375 ± 0.47240.0118Mann-Whitney test
RadiologyMild/Moderate24.00%42.11%0.0109Fisher exact test
Severe76.00%57.89%
AFB0/“+”18.75%55.00%0.0071Fisher exact test
“++”/“+++”81.25%45.00%
IFN-γ index29.2 ± 9.2229.3 ± 70.4<0.0001Mann-Whitney test
Proliferation index7.0 ± 0.9926.6 ± 2.9<0.0001Mann-Whitney test
Increase in the % of SLAMF1+ T cells2.2 ± 0.5010.9 ± 1.4<0.0001Mann-Whitney test
Low RespondersHigh RespondersPTest
Number5420
Age (year)33.94 ± 1.92230.59 ± 2.5730.1584Mann-Whitney test
SexFemale48.98%65.22%0.2169Fisher exact test
Male51.02%34.78%
EthnicityCaucasian78.72%95.00%0.1529Fisher exact test
American Indian21.28%5.00%
Albumin (g/dl)2.806 ± 0.10353.45 ± 0.160.0005Unpaired t test
Leucocytes (cells/ml)10109 ± 497.39920 ± 664.70.4157Mann-Whitney test
Lymphocytes (cells/ml)1368 ± 100.21845 ± 269.70.022Mann-Whitney test
Neutrophils (cells/ml)7566 ± 460.26866 ± 498.30.1804Mann-Whitney test
Monocytes (cells/mL)771.9 ± 66.76839.0 ± 83.60.2769Mann-Whitney test
Neutrophil/Lymphocyte Ratio7.609 ± 0.96144.693 ± 0.500.0255Mann-Whitney test
Time of Disease Evolution (months)4.227 ± 0.45362.375 ± 0.47240.0118Mann-Whitney test
RadiologyMild/Moderate24.00%42.11%0.0109Fisher exact test
Severe76.00%57.89%
AFB0/“+”18.75%55.00%0.0071Fisher exact test
“++”/“+++”81.25%45.00%
IFN-γ index29.2 ± 9.2229.3 ± 70.4<0.0001Mann-Whitney test
Proliferation index7.0 ± 0.9926.6 ± 2.9<0.0001Mann-Whitney test
Increase in the % of SLAMF1+ T cells2.2 ± 0.5010.9 ± 1.4<0.0001Mann-Whitney test

Immunological classification of TB patients as High and Low Responders (HR and LR) was performed according to the IFN-γ index; proliferation index and increase in the percentage of SLAMF1+ T cells in response to Mtb-Ag stimulation. Clinical symptoms analyzed in TB patients previous to hospital admission to establish the time (months) of disease evolution were: weight loss, night sweats, symptoms of malaise or weakness, persistent fever, presence of cough, history of shortness of breath, and hemoptysis. Radiological lesions: “mild” corresponds to patients with a single lobe involved and without visible cavities; “moderate” relates to patients presenting unilateral involvement of two or more lobes with cavities, if present, reaching a total diameter no greater than 4 cm; “severe” corresponds to bilateral disease with massive affectation and multiple cavities. Acid-Fast Bacilli (AFB) in sputum smear represent: AFB-, 0 bacilli count; AFB +, 1–9 bacilli/100 fields; AFB + +, 1–9 bacilli/10 fields; AFB + + + , 1–9 bacilli/field. Continuous data are expressed as mean ± SEM, and categorical data are expressed as number (percentages).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close